Similar articles

• Causes of allograft failure in recipients treated with and without antilymphocyte globulin.

  Sheil AG, May J, Rogers JH, Storey BG, Katran DC, Duggin GG, Johnson JR, Stewart JH. Sheil AG, et al. Transplant Proc. 1973 Mar;5(1):561-5. Transplant Proc. 1973. PMID: 4121179 No abstract available.
• [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients].

  Galvão MM, Mendes NF, Ramos OL, Sabbaga E. Galvão MM, et al. Rev Bras Pesqui Med Biol. 1972 Sep-Dec;5(5):251-8. Rev Bras Pesqui Med Biol. 1972. PMID: 4573042 Portuguese. No abstract available.
• Successful treatment of acute cardiac homograft rejection without antilymphocyte globulin.

  Kauffman HM Jr, Lepley D, Johnson D, Kuban D. Kauffman HM Jr, et al. Laval Med. 1970 Feb;41(2):260-1. Laval Med. 1970. PMID: 4102120 No abstract available.
• Antirejection drugs and procedures.

  Chatterjee SN. Chatterjee SN. Am J Surg. 1973 Nov;126(5):678-82. doi: 10.1016/s0002-9610(73)80021-2. Am J Surg. 1973. PMID: 4129988 Review. No abstract available.
• [Antilymphocyte globulin today].

  Brendel W. Brendel W. Munch Med Wochenschr. 1973 Feb 16;115(7):241-8. Munch Med Wochenschr. 1973. PMID: 4632641 Review. German. No abstract available.